Although direct blockade of TNF or INF-γ has not shown clinically useful results in improving COVID-19 prognosis so far, the downstream pathways activated by those two cytokines, such as the JAK/STAT1 pathway that play a central role in hyperinflammation and cell death, may be more promising targets [16]. This evidence concerns the gene TNF and COVID-19.